Goldman Sachs cuts Eastman Chemical stock price target on margin pressures

Goldman Sachs reduced its price target for Eastman Chemical (NYSE:EMN) to $72 from $73, citing Q3 earnings misses and margin pressures. The company reported adjusted EPS of $1.84 and adjusted EBIT of $305 million, both below expectations. Eastman Chemical also lowered its full-year 2026 adjusted EPS guidance to $6.00-$6.20, below consensus. The stock trades at $66.53, with a P/E ratio of 17.27 and a market cap of $7.61 billion.

Original reporting
Published Nov 2, 2026, 9:06 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 9:28 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$EMN
Bearish
medium confidence
Mentioned
$EMN
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$EMNBearishMed
01

Why it matters

The downgrade reinforces negative sentiment and may accelerate a sell‑off, but the DOE grant and 2027 guidance could provide a floor.

02

Market read

The article provides fresh earnings and analyst coverage data that can affect EMN's short‑term price action.

03

What to watch

Potential upside from the DOE grant and upcoming 2027 fiber earnings recovery.

Relevance 7/10Novelty 7/10Timing: pre‑market today

Background

Eastman Chemical reported Q3 2026 results that fell short of expectations, prompting Goldman Sachs to cut its price target.

Company-level read

Ticker impact

$EMNBearishMedium confidence
Context

Goldman Sachs lowered its price target on Eastman Chemical after the company reported a Q3 earnings miss and weaker guidance.

Expected impact

likely downward pressure as the market prices in the lower target and earnings miss

Evidence & confidence

Analyst downgrade combined with missed earnings and guidance typically leads to near‑term price declines.

Market effects

Chemicals sector may face broader scrutiny as price‑cost pressures affect peers.

U.S. market participants may adjust exposure to specialty chemicals.

Limited to investors tracking industrial and specialty chemical stocks.

Counterpoint

If the earnings miss is viewed as a temporary setback, the stock could be undervalued after the downgrade.

Key entities

  • Goldman Sachs

    Reduced EMN price target to $72 from $73.

  • Eastman Chemical

    Reported Q3 earnings miss and lowered full‑year guidance.

Related articles

$EMNHighAI 8/10

Eastman Q3 2026 slides show margin gains despite estimate miss

Eastman Chemical (EMN) reported Q3 2026 earnings of $1.84/share, missing estimates of $1.94, with revenue at $2.39B, slightly below the $2.41B forecast. Despite this, margins improved, with adjusted EBIT rising to $305M (12.8% margin) from $210M (9.5%) a year ago. The company cited higher selling prices, favorable price-cost dynamics, and cost reduction initiatives as drivers. Segment performance varied, with Additives & Functional Products showing the strongest results.

$EMNMed

Eastman Chemical Co (EMN) (Q3 2026) Earnings Call Highlights: DOE Grant Restored

Eastman Chemical (EMN) discussed Q3 2026 earnings, noting restored DOE grant support for expansion projects, with DOE covering up to 50% of CapEx. CEO Mark Costa expects the second plant to cost less due to acquired assets. Propylene-propane spread is expected to narrow, adding $30M-$40M to 2027 earnings. Advanced Materials faces a $30M Q4 headwind, with January price increases aiming to offset costs. Operational delays impacted Q3 results, but lines are now running well.

$EMNMed

What Eastman Chemical (EMN) Said on Its Q3 Earnings Call

Eastman Chemical (EMN) expects circular-economy revenue growth to continue, aiming for $100M+ in 2027. It lowered its full-year operating cash flow forecast to $850M due to inflationary pressures. Advanced Materials faces Q4 cost pressures but anticipates price increases in 2027. Volume growth is expected in several segments, with a new ethylene-to-propylene unit planned for 2028.

$EMNMed

DOE reinstates $375 million Eastman award

The U.S. Department of Energy (DOE) reinstated a $340 million award to Eastman Chemical Company for its molecular recycling projects, after initially canceling a $375 million award. The updated plan includes increasing capacity at its Kingsport plant and repurposing underutilized U.S. recycling infrastructure. Eastman expects $100 million in incremental revenue growth in 2026 and over $100 million in 2027 from its Kingsport plant, according to the company.